These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
460 related items for PubMed ID: 19136741
1. Hemorheological changes in solid tumor patients after treatment with recombinant erythropoetin. Muravyov AV, Cheporov SV, Kislov NV, Volkova EL. Clin Hemorheol Microcirc; 2009; 41(1):39-47. PubMed ID: 19136741 [Abstract] [Full Text] [Related]
2. Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients. Muravyov AV, Cheporov SV, Kislov NV, Bulaeva SV, Maimistova AA. Clin Hemorheol Microcirc; 2010; 44(2):115-23. PubMed ID: 20203366 [Abstract] [Full Text] [Related]
3. Red blood cell aggregation changes are depended on its initial value: Effect of long-term drug treatment and short-term cell incubation with drug. Muravyov AV, Tikhomirova IA, Maimistova AA, Bulaeva SV, Mikhailov PV, Kislov NV. Clin Hemorheol Microcirc; 2011; 48(4):231-40. PubMed ID: 22012828 [Abstract] [Full Text] [Related]
4. Extra- and intracellular signaling pathways under red blood cell aggregation and deformability changes. Muravyov AV, Tikhomirova IA, Maimistova AA, Bulaeva SV. Clin Hemorheol Microcirc; 2009; 43(3):223-32. PubMed ID: 19923692 [Abstract] [Full Text] [Related]
5. The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients. Muravyov AV, Yakusevich VV, Surovaya L, Petrochenko A. Clin Hemorheol Microcirc; 2004; 31(4):251-6. PubMed ID: 15567894 [Abstract] [Full Text] [Related]
6. Macro- and microrheological parameters of blood in patients with cerebral and peripheral atherosclerosis: the molecular change mechanisms after pentoxifylline treatment. Muravyov AV, Bulaeva SV, Tikhomirova IA, Zamishlayev AV, Uzikova EV, Miloradov MJ. Clin Hemorheol Microcirc; 2011; 49(1-4):431-9. PubMed ID: 22214714 [Abstract] [Full Text] [Related]
7. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A. Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970 [Abstract] [Full Text] [Related]
11. Haemorheological changes in uraemic children in response to erythropoietin treatment. Böhler T, Leo A, Linderkamp O, Braun A, Schärer K. Nephrol Dial Transplant; 1993 Sep; 8(2):140-5. PubMed ID: 8384334 [Abstract] [Full Text] [Related]
20. Hemorheological parameters in children with iron-deficiency anemia and the alterations in these parameters in response to iron replacement. Halis H, Bor-Kucukatay M, Akin M, Kucukatay V, Bozbay I, Polat A. Pediatr Hematol Oncol; 2009 Nov; 26(3):108-18. PubMed ID: 19382032 [Abstract] [Full Text] [Related] Page: [Next] [New Search]